Sucampo Pharma Inc (SCMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 65,775 | 64,356 | 61,633 | 62,562 | 25,559 |
Marketable Securities | 24,452 | 54,524 | 72,434 | 42,750 | 51,552 |
Receivables | 20,292 | 13,046 | 12,179 | 14,769 | 17,997 |
Income taxes - deferred | 163 | 243 | 315 | 963 | 88 |
Other current assets | 3,057 | 0 | 0 | 0 | 0 |
TOTAL | $114,916 | $134,543 | $149,736 | $125,025 | $97,418 |
Non-Current Assets | |||||
PPE Net | 1,669 | 2,025 | 2,274 | 2,275 | 2,265 |
Investments And Advances | 998 | 5,028 | 19,167 | 16,222 | 9,400 |
Intangibles | 8,364 | 3,070 | 0 | 0 | 0 |
Other Non-Current Assets | 31,622 | 4,607 | 8,828 | 7,272 | 944 |
TOTAL | $42,653 | $14,730 | $30,269 | $25,769 | $12,609 |
Total Assets | $157,569 | $149,273 | $180,005 | $150,794 | $110,027 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 6,978 | 4,199 | 3,210 | 1,433 | 3,313 |
Accrued Expenses | 13,648 | 10,216 | 6,695 | 9,764 | 8,730 |
TOTAL | $47,081 | $40,002 | $22,423 | $26,796 | $13,105 |
Non-Current Liabilities | |||||
Long Term Debt | 39,227 | 44,439 | N/A | N/A | N/A |
Deferred Revenues | 3,888 | 4,987 | 10,565 | 15,599 | 1,062 |
Other Non-Current Liabilities | 2,603 | 2,681 | 3,627 | 2,147 | 1,768 |
TOTAL | $71,894 | $55,441 | $12,270 | $10,208 | $10,394 |
Total Liabilities | $118,975 | $95,443 | $34,693 | $37,004 | $23,499 |
Shareholders' Equity | |||||
Shares Outstanding, K | 41,895 | 41,851 | 41,847 | 41,843 | 41,734 |
Common Shares | 419 | 418 | 418 | 418 | 417 |
Retained earnings | -38,936 | -21,630 | 33,150 | 14,775 | -10,176 |
Other shareholders' equity | 18,154 | 16,574 | 12,847 | 354 | -393 |
TOTAL | $38,594 | $53,830 | $145,312 | $113,790 | $86,528 |
Total Liabilities And Equity | $157,569 | $149,273 | $180,005 | $150,794 | $110,027 |